These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36867357)

  • 21. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
    Kim H; Im HJ; Koh KN; Kang SH; Yoo JW; Choi ES; Cho YU; Jang S; Park CJ; Seo JJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):965-974. PubMed ID: 30639824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical management of aplastic anemia.
    Dezern AE; Brodsky RA
    Expert Rev Hematol; 2011 Apr; 4(2):221-30. PubMed ID: 21495931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Value of a Protocolized In-Depth Evaluation of Pediatric Bone Marrow Failure: A Multi-Center Prospective Cohort Study.
    Atmar K; Ruivenkamp CAL; Hooimeijer L; Nibbeling EAR; Eckhardt CL; Huisman EJ; Lankester AC; Bartels M; Santen GWE; Smiers FJ; van der Burg M; Mohseny AB
    Front Immunol; 2022; 13():883826. PubMed ID: 35572556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
    Andolina JR; Reinish AL; Akhtar R; Noronha S; Shand JC; Girvin A; Korones DN; Bruckner LB; Mullen CA; Curran KJ; Boulad F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27218. PubMed ID: 29722478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
    Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
    Front Immunol; 2022; 13():837335. PubMed ID: 35178053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
    Li Q; Li B; Luo C; Wang J; Luo C; Ding L; Chen J
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):817-23. PubMed ID: 26758319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic Hematopoietic Stem Cell Transplant for Severe Aplastic Anemia: Current State and Future Directions.
    Sun Q; Wu B; Zhu Z; Sun C; Xu J; Long H; Huang Y; Xu J; Song C
    Curr Stem Cell Res Ther; 2018; 13(5):350-355. PubMed ID: 28245775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA-mismatched bone marrow transplantation with post-transplant cyclophosphamide for pediatric patients with aplastic anemia].
    Okamoto K; Osone S; Matsuura A; Asazuma M; Matsuoka T; Kanayama T; Imamura T; Hosoi H
    Rinsho Ketsueki; 2022; 63(1):45-50. PubMed ID: 35135951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of aplastic anemia after failure of frontline immunosuppression.
    Pierri F; Dufour C
    Expert Rev Hematol; 2019 Oct; 12(10):809-819. PubMed ID: 31311355
    [No Abstract]   [Full Text] [Related]  

  • 32. How I treat acquired aplastic anemia.
    Scheinberg P; Young NS
    Blood; 2012 Aug; 120(6):1185-96. PubMed ID: 22517900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.
    Piekarska A; Pawelec K; Szmigielska-Kapłon A; Ussowicz M
    Front Immunol; 2024; 15():1378432. PubMed ID: 38646536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic stem cell transplantation for acquired aplastic anemia.
    Georges GE; Storb R
    Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
    Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.
    Devillier R; Dalle JH; Kulasekararaj A; D'aveni M; Clément L; Chybicka A; Vigouroux S; Chevallier P; Koh M; Bertrand Y; Michallet M; Zecca M; Yakoub-Agha I; Cahn JY; Ljungman P; Bernard M; Loiseau P; Dubois V; Maury S; Socié G; Dufour C; Peffault de Latour R
    Haematologica; 2016 Jul; 101(7):884-90. PubMed ID: 27056924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation for bone marrow failure: current issues.
    Peffault de Latour R
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):90-98. PubMed ID: 27913467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hematopoietic stem cell transplantation for acquired aplastic anemia].
    Yamazaki H
    Rinsho Ketsueki; 2015 Oct; 56(10):2153-9. PubMed ID: 26458455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
    Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.